Zelenskyy says at least 22 people killed in Russian attacks on Ukraine, hours after Trump put pressure on Moscow – Europe live

Overnight Russian attacks in Ukraine killed 22, prompting President Zelenskyy to demand tougher sanctions and the Kremlin to dismiss US President Trump's '10-12 day' peace deadline, signaling continued geopolitical instability. Concurrently, a significant 'gulf in understanding' has emerged regarding the recent EU-US trade deal: US Commerce Secretary Lutnick claims a 'masterclass' victory with 15% tariffs on EU autos, pharma, and semiconductors, alongside an implied agreement against digital taxes, while EU officials assert digital regulation was not on the table and the deal is a non-binding 'roadmap,' creating immediate confusion over pharmaceutical tariffs and portending ongoing trade friction.

Analysis

A significant divergence in an EU-US trade deal narrative, coupled with escalating military conflict in Ukraine, injects considerable uncertainty into the market. US Commerce Secretary Lutnick has declared a major victory, citing a comprehensive agreement for the EU to pay a 15% tariff on key exports like autos and pharmaceuticals, and to refrain from imposing digital services taxes. Conversely, EU officials characterize the deal as a non-binding "political roadmap," explicitly refuting any concession on their right to regulate the digital space autonomously. This "gulf in understanding" creates immediate ambiguity, particularly for European pharmaceutical and auto sectors, which face the prospect of new tariffs as soon as this week. The US claims this deal protected firms like Sanofi from even harsher measures, such as forced relocation. Simultaneously, renewed Russian aggression in Ukraine, resulting in 22 civilian deaths, has prompted Ukrainian President Zelenskyy to call for more severe sanctions, while the Kremlin dismisses a new US-imposed "10-12 day" peace deadline, signaling continued geopolitical instability.

Key Decisions for Investors

• Given the dual headwinds of escalating geopolitical conflict and significant transatlantic trade friction, investors should prepare for heightened market volatility, closely monitoring the '10-12 day' deadline on Russia as a near-term catalyst.
• Investors with exposure to European auto and pharmaceutical sectors, including Sanofi, must watch for official clarification on the 15% US tariff, as the conflicting US and EU statements create significant short-term pricing risk.
• Recognize that the threat of an EU digital services tax impacting US tech giants remains a key unresolved issue, representing a persistent regulatory overhang despite US assertions that the matter is settled.